Omniscan

OMNISCAN Uses MRI to visualize lesions with abnormal vascularity which may result in the detection of a malignancy, such as neoplasms, abscesses, subacute infarcts and malignant and nonmalignant tumors.

About Omniscan

OMNISCAN was launched in the U.S. in 1993 to provide contrast enhancement of the central nervous system (CNS) to detect lesions of the brain, spinal cord, and associated tissues. It uses MRI to visualize lesions with abnormal vascularity which may result in the detection of a malignancy, such as neoplasms, abscesses, subacute infarcts and malignant and nonmalignant tumors.

Features

Product Name

Omniscan

Product Type

Contrast Media

Request Call Back

First Name *	This field is required.
Last Name *	This field is required.
Organization *	This field is required.
Phone 1 *	This field is required.
Phone 2
Email *	This field is required.
Country

Reason for Call

700

First Name:*	Last Name:*
Email:*	Phone:*
Company Name:*
Comment:

Enter Your Email Address to Receive a Copy of MedicExhange Member Demograhpics

Omniscan

About Omniscan

Features

Product Name

Product Type

Request Call Back

Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics